Literature DB >> 6380466

Treatment of glaucoma using minidrops of clonidine.

G Petursson, R Cole, C Hanna.   

Abstract

A single regular (70 microL) or mini (15 microL) eyedrop of 0% (placebo), 0.25%, and 0.50% strengths of clonidine hydrochloride was administered to 16 patients with open-angle glaucoma in a double-masked crossover study. Both the regular drops and minidrops of 0.25% and 0.50% concentrations of the drug substantially lowered the intraocular pressure over a five-hour period as compared with the placebo. Only the regular drops of 0.50% clonidine substantially lowered the systemic BP. These results indicate the value of using a smaller volume of clonidine drop as an ocular hypotensive agent to avoid systemic effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380466     DOI: 10.1001/archopht.1984.01040030958024

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

Review 1.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

2.  The role of apraclonidine hydrochloride in laser therapy for glaucoma.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1989

3.  Precision Ocular Drug Delivery Via Aerosol Ring Vortices.

Authors:  Matthew J Herpin; Hugh D C Smyth
Journal:  Pharm Res       Date:  2017-08-07       Impact factor: 4.200

Review 4.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

5.  Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment.

Authors:  Shiva Kumar; Roopa Karki; Marreddy Meena; Tigari Prakash; Tanniru Rajeswari; Divakar Goli
Journal:  J Adv Pharm Technol Res       Date:  2011-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.